Neutralizing antibody levels associated with injectable and aerosolized Ad5-nCoV boosters and BA.2 infection

Fuzhen Wang(Chinese Center For Disease Control and Prevention), Wenjie Tan(Hebei Medical University), Zhijie An(Shihezi University), Li Zhao(BGI Group (China)), Lin Tang(Chinese Center For Disease Control and Prevention), Haitao Yang(Yunnan Center for Disease Control And Prevention), George F. Gao(Chinese Academy of Sciences), Jiao Ren(National Institute for Viral Disease Control and Prevention), Yao Deng(National Institute for Viral Disease Control and Prevention), Dan Wu(London School of Hygiene & Tropical Medicine), Xianfeng Zhang(Hubei Provincial Center for Disease Control and Prevention), Baoying Huang(National Institute for Viral Disease Control and Prevention), Zundong Yin(Chinese Center For Disease Control and Prevention), Weijun Hu, Cangning Wang(Yunnan Center for Disease Control And Prevention), Xiaoyu Liu(The Ohio State University), Shaobai Zhang, Xiaoqiang Liu(Yunnan Center for Disease Control And Prevention), Fei Ye(Army Medical University), Qianqian Liu(Yunnan University), Xiaoqi Wang(Soochow University), Wenbo Xu(National Institute for Viral Disease Control and Prevention), Hui Zheng(Chinese Center For Disease Control and Prevention), Yan Zheng(Cornell University), Xuhua Guan(Hubei Provincial Center for Disease Control and Prevention), Wenling Wang(National Institute for Viral Disease Control and Prevention), Ruize Wang, Lei Wang(Nanyang Technological University), Siquan Wang(Hubei Provincial Center for Disease Control and Prevention)
BMC Medicine
July 3, 2023
Cited by 14


Related Papers